Rare‐Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease
Movement Disorders · 2026-09 · 41 (9) · 2349-2356
DOI: 10.1002/mds.70391 ↗Kurz gefasst
Fachartikel in der Zeitschrift Movement Disorders, online erschienen am 10.06.2026. Verfasst von Konstantin Senkevich und 21 weiteren Autor:innen. Beteiligte Einrichtung: The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada. Hauptthemen laut MEDLINE: Parkinson Disease, Lysosomes, Gangliosides. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 46 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: NIH HHS, Calcul Québec and the Digital Research Alliance of Canada, Intramural NIH HHS.
Abstract (Originalsprache)
Background
Lysosomal dysfunction is central to Parkinson's disease (PD) pathogenesis, with GBA1 representing the strongest established genetic risk factor. Numerous other genes involved in lysosomal sphingolipid, glycosphingolipid, and ceramide metabolism have been proposed as contributors to PD, highlighting the need for genetic analyses across these pathways.
Objectives
The aim was to evaluate the contribution of rare variants across lysosomal genes to PD risk.
Methods
We analyzed rare variants (minor allele frequency ≤0.01) across 36 lysosomal genes in 8267 individuals with PD and 68,208 controls, including 793 early‐onset PD (≤50 years) cases. Targeted sequencing was performed in four cohorts at McGill University (3456 cases and 2664 controls) and combined with whole‐genome sequencing data from the United Kingdom (UK) Biobank (2848 cases, 62,451 controls) and the Accelerating Medicines Partnership‐PD cohort (1963 cases, 3093 controls). Associations were tested using Sequence Kernel Association Test‐Optimal across variant classes (rare variants, nonsynonymous, loss‐of‐function, and predicted damaging variants with combined annotation‐dependent depletion score >20), followed by meta‐analysis across cohorts. Domain‐level analyses were performed for variants located within protein domains. False discovery rate (FDR) correction was applied.
Results
Meta‐analysis identified a significant association between rare variants in ST3GAL3 and Parkinson's disease (Pfdr = 0.04). Domain‐based analyses showed enrichment of nonsynonymous variants within the β‐acetyl‐hexosaminidase–like domain of HEXA ( P = 8.0 × 10 −4 ), although this signal did not survive correction (Pfdr = 0.154). In early‐onset PD, domain‐based analyses identified significant associations in NAGLU (Pfdr = 7.3 × 10 −6 ) and ST3GAL5 (Pfdr = 0.03).
Conclusions
Rare variants across multiple lysosomal pathways, particularly those related to sialylation, ganglioside metabolism, ceramide biology, and lysosomal proteolysis, may contribute to PD susceptibility beyond GBA1 , highlighting pathways for future replication and investigation. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The Neuro (Montreal Neurological Institute-Hospital), McGill University, Montreal, Quebec, Canada.
- Department of Neurology and Neurosurgery, McGill University, Montréal, Quebec, Canada.
- Department of Specialized Medicine, Division of Medical Genetics, McGill University Health Centre, Montreal, Quebec, Canada.
- Department of Human Genetics, McGill University, Montréal, Quebec, Canada.
- Department of Neurology, College of Physicians and Surgeons, Columbia University Medical Center, New York, New York, USA.
- Department of Clinical Neurosciences and Department of Radiology, University of Calgary, Calgary, Alberta, Canada.
ORCID-Profile: Eric Yu, Lior Greenbaum, Ziv Gan-Or
Förderung
- NIH HHS
- Calcul Québec and the Digital Research Alliance of Canada
- Intramural NIH HHS
- McGill University
- Consortium canadien en neurodégénérescence associée au vieillissement
- Parkinson's Foundation
- G-Can (GBA1-Canada)
- Canada First Research Excellence Fund
Zitieren
APA
Senkevich, K., Parlar, S. C., Chantereault, C., Liu, L., Yu, E., Rudakou, U., Ahmad, J., Ruskey, J. A., Asayesh, F., Spiegelman, D., Waters, C., Monchi, O., Dauvilliers, Y., Dupré, N., Greenbaum, L., Hassin-Baer, S., Miliukhina, I., Timofeeva, A., Emelyanov, A., …, & Gan-Or, Z. (2026). Rare‐Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease. Movement Disorders, 41(9), 2349-2356. https://doi.org/10.1002/mds.70391
Vancouver
Senkevich K, Parlar SC, Chantereault C, Liu L, Yu E, Rudakou U, et al. Rare‐Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease. Movement Disorders. 2026;41(9):2349-2356. doi:10.1002/mds.70391
BibTeX
@article{Senkevich2026,
author = {Senkevich, Konstantin and Parlar, Sitki Cem and Chantereault, Cloe and Liu, Lang and Yu, Eric and Rudakou, Uladzislau and Ahmad, Jamil and Ruskey, Jennifer A and Asayesh, Farnaz and Spiegelman, Dan and Waters, Cheryl and Monchi, Oury and Dauvilliers, Yves and Dupré, Nicolas and Greenbaum, Lior and Hassin-Baer, Sharon and Miliukhina, Irina and Timofeeva, Alla and Emelyanov, Anton and Pchelina, Sofya and Alcalay, Roy N and Gan-Or, Ziv},
title = {Rare‐Variant Burden across Lysosomal Genes Implicates Sialylation and Ganglioside Metabolism in Parkinson's Disease},
journal = {Movement Disorders},
year = {2026},
volume = {41},
number = {9},
pages = {2349--2356},
doi = {10.1002/mds.70391}
}
EUVIMED